−398KRW
−12.67 BKRW
5.29 BKRW
27.46 M
About OLIPASS
Sector
Industry
CEO
Shin Chung
Website
Headquarters
Yongin
Employees (FY)
74
Founded
2006
ISIN
KR7244460002
FIGI
BBG00PYL5X39
OliPass Corp. develops biological products. It offers artificial gene and gene therapy. The company was founded by Shin Chung on November 16, 2006 and is headquartered in Yongin, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 244460 is 491.00 KRW — it has increased by 2.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OLIPASS stocks are traded under the ticker 244460.
Yes, you can track OLIPASS financials in yearly and quarterly reports right on TradingView.
Like other stocks, 244460 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OLIPASS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 74.00 employees. See our rating of the largest employees — is OLIPASS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OLIPASS EBITDA is −15.59 B KRW, and current EBITDA margin is −315.88%. See more stats in OLIPASS financial statements.